Prasad Abhiram, Higano Stuart T, Al Suwaidi Jassim, Holmes David R, Mathew Verghese, Pumper Geralyn, Lennon Ryan J, Lerman Amir
Division of Cardiovascular Diseases and Department of Internal Medicine, Center for Coronary Physiology and Imaging, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.
Am Heart J. 2003 Sep;146(3):549-54. doi: 10.1016/S0002-8703(03)00364-8.
Coronary endothelial dysfunction may potentially lead to myocardial ischemia and to the progression of heart failure. Though endothelial dysfunction is associated with advanced heart failure in humans, relatively little is known regarding their temporal relationship. Thus, the current study was designed to test the hypothesis that coronary endothelial dysfunction is present in patients with asymptomatic left ventricular dysfunction.
Three hundred patients without symptoms of heart failure, with normal or mildly diseased coronary arteries at angiography underwent coronary vascular reactivity evaluation using intracoronary adenosine, acetylcholine (ACH) and nitroglycerin. Patients were divided into 2 groups based on the left ventricular ejection fraction (EF): patients with asymptomatic left ventricular dysfunction (ALVD), EF <45% (n = 11); and patients with EF > or =45% (n = 289, controls). Except for a lower high-density lipoprotein level in patients with ALVD, there were no significant differences between the groups in regards to conventional cardiovascular risk factors. There was no difference in the change (mean +/- SE) in epicardial diameter in response to ACH (-21.7% +/- 7.2% vs -13.8% +/- 1.5%, P =.3). The change in coronary blood flow in response to ACH was significantly attenuated in the patients with ALVD when compared to the controls (-18.5% +/- 14.9% vs 74.0% +/- 7.2%, P <.013). By multivariate analysis, EF was an independent predictor of coronary microvascular dilation with ACH (P <.001).
The current study demonstrates that coronary microvascular endothelial dysfunction is present in ALVD. Thus, coronary endothelial dysfunction may be an early event in the pathophysiology of heart failure.
冠状动脉内皮功能障碍可能会导致心肌缺血以及心力衰竭的进展。虽然内皮功能障碍与人类晚期心力衰竭有关,但其时间关系却知之甚少。因此,本研究旨在验证无症状左心室功能障碍患者存在冠状动脉内皮功能障碍这一假设。
300例无心力衰竭症状、血管造影显示冠状动脉正常或轻度病变的患者,使用冠状动脉内腺苷、乙酰胆碱(ACH)和硝酸甘油进行冠状动脉血管反应性评估。根据左心室射血分数(EF)将患者分为两组:无症状左心室功能障碍(ALVD)患者,EF<45%(n = 11);EF≥45%的患者(n = 289,对照组)。除了ALVD患者的高密度脂蛋白水平较低外,两组在传统心血管危险因素方面无显著差异。ACH刺激后心外膜直径的变化(平均值±标准误)无差异(-21.7%±7.2% vs -13.8%±1.5%,P = 0.3)。与对照组相比,ALVD患者ACH刺激后冠状动脉血流的变化显著减弱(-18.5%±14.9% vs 74.0%±7.2%,P < 0.013)。多因素分析显示,EF是ACH诱导冠状动脉微血管扩张的独立预测因素(P < 0.001)。
本研究表明ALVD患者存在冠状动脉微血管内皮功能障碍。因此,冠状动脉内皮功能障碍可能是心力衰竭病理生理过程中的早期事件。